Familial Multiple Nevi FlammeiSymptoms, Doctors, Treatments, Advances & More
Familial Multiple Nevi Flammei Overview
Learn About Familial Multiple Nevi Flammei
- Nevi flammei, familial multiple
- Port-wine stain familial multiple
RGG Medicine PLLC
Roy Geronemus is a Dermatologist practicing medicine in New York, New York. Dr. Geronemus is rated as an Elite provider by MediFind in the treatment of Familial Multiple Nevi Flammei. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Familial Multiple Nevi Flammei, Stork Bite, Pigmented Purpuric Dermatosis, and Melasma.
Wenxin Yu practices practicing medicine in Huangpu, China. Yu is rated as an Elite expert by MediFind in the treatment of Familial Multiple Nevi Flammei. They are also highly rated in 3 other conditions, according to our data. Their clinical expertise encompasses Familial Multiple Nevi Flammei, Stork Bite, Cafe-Au-Lait Spots, and Hemangioma.
Avera Dermatology — Pierre
Dr. (Joyce) Wesley Fletcher is a dermatologist at Avera Medical Group in Pierre, located in the Helmsley Center at Avera St. Mary's Hospital. Dr. Fletcher is rated as an Experienced provider by MediFind in the treatment of Familial Multiple Nevi Flammei. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, and Neurocutaneous Melanosis.
Summary: The goal of this observational study is to learn about the neuropsychological profile of Sturge-Weber Syndrome (SWS) in children and adults with this rare neurocutaneous condition. SWS affects approximately 1 in 50,000 live births and is characterized by brain blood vessel malformations, facial port-wine stains, and abnormal vascularization in the brain, skin, and eyes. Patients are at high risk f...
Summary: This is a multi-center, randomized, double-blind, vehicle-controlled, and sequential group Phase 2 study. Eligible subjects aged 18 to 75 years old with PWB will receive Hemoporfin PDT or vehicle PDT in 8-week cycles at fixed drug dose (5 mg/kg) and different light fluence.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
